See more : Mount Burgess Mining N.L. (MTBMF) Income Statement Analysis – Financial Results
Complete financial analysis of Chiang Mai Ram Medical Business Public Company Limited (CMR.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chiang Mai Ram Medical Business Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- nFinanSe Inc. (NFSE) Income Statement Analysis – Financial Results
- Accolade, Inc. (ACCD) Income Statement Analysis – Financial Results
- Bullfrog AI Holdings, Inc. Warrants (BFRGW) Income Statement Analysis – Financial Results
- Bowl America Incorporated (BWL-A) Income Statement Analysis – Financial Results
- Brembo N.V. (0RPV.L) Income Statement Analysis – Financial Results
Chiang Mai Ram Medical Business Public Company Limited (CMR.BK)
About Chiang Mai Ram Medical Business Public Company Limited
Chiang Mai Ram Medical Business Public Company Limited, together with its subsidiaries, operates a medical care center in Thailand. It offers medical services in the areas of internal medicine, cardiology, general practice, pediatric, orthopedic and general surgery, pediatric surgery, obstetrics-gynecology, radiology, dentistry, anesthetic, ENT, and eye; and operates sub-specialty clinics for urology, neurology, endocrinology, oncology, hematology, plastic surgery, GI tract, and dermatology, as well as infertile and gynecologic oncology clinics. The company also provides dental, X-ray, CT colonoscopy, cardiac catheterization, gynecologic cancer, back pain, physical therapy and rehabilitation, operating theatre, laboratory examination, real-time PCR, ambulance, and CRD and health check-up services; and insurance products. It operates a medical care center under the Lanna Hospital name. The company was founded in 1974 and is headquartered in Chiang Mai, Thailand. Chiang Mai Ram Medical Business Public Company Limited is a subsidiary of Vibhavadi Medical Center Public Company Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.07B | 5.20B | 4.19B | 3.67B | 3.93B | 3.94B | 3.75B | 3.48B | 3.29B | 2.90B | 2.66B | 2.25B | 1.95B | 1.81B | 1.67B | 1.49B | 347.64M | 300.91M | 268.95M | 246.16M | 232.68M |
| Cost of Revenue | 3.91B | 3.79B | 3.26B | 2.86B | 3.02B | 2.83B | 2.55B | 2.34B | 2.13B | 1.95B | 1.75B | 1.58B | 1.38B | 1.27B | 1.16B | 1.07B | 233.57M | 203.50M | 188.78M | 172.17M | 158.78M |
| Gross Profit | 1.15B | 1.41B | 937.57M | 806.76M | 903.57M | 1.10B | 1.19B | 1.15B | 1.16B | 947.12M | 914.19M | 675.81M | 571.37M | 545.80M | 503.50M | 413.07M | 114.08M | 97.41M | 80.17M | 73.99M | 73.90M |
| Gross Profit Ratio | 22.74% | 27.13% | 22.36% | 21.99% | 23.01% | 28.04% | 31.82% | 32.89% | 35.30% | 32.68% | 34.32% | 29.99% | 29.28% | 30.10% | 30.22% | 27.76% | 32.81% | 32.37% | 29.81% | 30.06% | 31.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 712.34M | 657.84M | 528.56M | 537.41M | 535.07M | 512.26M | 489.21M | 476.16M | 398.75M | 351.57M | 306.63M | 301.10M | 268.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 712.34M | 657.84M | 528.56M | 537.41M | 535.07M | 512.26M | 489.21M | 476.16M | 398.75M | 351.57M | 306.63M | 301.10M | 268.40M | 257.23M | 245.55M | 240.44M | 64.56M | 56.24M | 50.67M | 44.67M | 40.12M |
| Other Expenses | -178.62M | 64.48M | 50.86M | 46.74M | 38.53M | 31.09M | 26.38M | 27.24M | 25.40M | 24.06M | 13.30M | 11.48M | 14.95M | -51.53M | -50.03M | 727.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 533.72M | 657.84M | 528.56M | 537.41M | 535.07M | 512.26M | 489.21M | 476.16M | 398.75M | 351.57M | 306.63M | 301.10M | 283.35M | 205.70M | 195.51M | 241.17M | 64.56M | 56.24M | 50.67M | 44.67M | 40.12M |
| Cost & Expenses | 4.45B | 4.45B | 3.78B | 3.40B | 3.56B | 3.34B | 3.04B | 2.81B | 2.53B | 2.30B | 2.06B | 1.88B | 1.66B | 1.47B | 1.36B | 1.32B | 298.13M | 259.74M | 239.44M | 216.84M | 198.91M |
| Interest Income | 0.00 | 37.08M | 1.94M | 4.77M | 5.69M | 8.43M | 8.14M | 9.88M | 17.37M | 19.90M | 10.49M | 6.40M | 4.24M | 4.00M | -50.03M | -52.74M | -0.12 | 0.00 | -0.51 | 0.14 | 0.00 |
| Interest Expense | 148.17M | 119.12M | 86.04M | 75.76M | 89.33M | 90.89M | 87.35M | 55.68M | 48.38M | 48.64M | 46.13M | 47.19M | 41.70M | 51.53M | 50.03M | 52.74M | 8.31K | 282.68 | 126.38K | 325.57K | 1.39M |
| Depreciation & Amortization | 496.50M | 467.10M | 344.34M | 247.01M | 262.60M | 248.68M | 229.90M | 202.61M | 167.54M | 143.44M | 135.25M | 127.45M | 110.85M | 103.16M | -47.62M | 76.41M | 23.08M | 25.41M | 26.80M | 26.96M | 27.26M |
| EBITDA | 1.11B | 1.40B | 872.49M | 600.29M | 763.67M | 900.32M | 1.00B | 927.32M | 987.70M | 799.51M | 782.36M | 536.91M | 439.51M | 411.64M | 260.38M | 284.21M | 72.61M | 66.58M | 56.43M | 56.27M | 61.03M |
| EBITDA Ratio | 21.98% | 25.10% | 19.57% | 16.37% | 17.68% | 22.67% | 26.06% | 26.09% | 29.97% | 27.70% | 29.18% | 23.68% | 20.66% | 22.70% | 15.63% | 19.10% | 20.89% | 22.13% | 20.98% | 22.86% | 26.23% |
| Operating Income | 618.03M | 900.86M | 528.16M | 385.73M | 431.54M | 591.19M | 703.47M | 669.09M | 761.96M | 595.55M | 607.57M | 374.72M | 288.02M | 340.10M | 307.99M | 171.90M | 49.52M | 41.17M | 29.50M | 29.32M | 33.78M |
| Operating Income Ratio | 12.20% | 17.31% | 12.60% | 10.52% | 10.99% | 15.02% | 18.77% | 19.21% | 23.18% | 20.55% | 22.81% | 16.63% | 14.76% | 18.76% | 18.48% | 11.55% | 14.24% | 13.68% | 10.97% | 11.91% | 14.52% |
| Total Other Income/Expenses | -133.03M | -65.39M | -74.09M | -74.63M | -995.39K | -54.23M | -45.99M | -23.37M | -2.38M | -12.18M | -19.89M | -18.65M | 1.54M | -53.65M | 23.45M | -69.58M | -122.80M | -288.00 | -125.81K | -325.57K | -1.39M |
| Income Before Tax | 485.00M | 799.77M | 454.07M | 311.10M | 430.54M | 571.49M | 690.78M | 668.40M | 784.98M | 627.28M | 611.74M | 376.15M | 289.56M | 286.46M | 331.44M | 69.19M | 49.52M | 41.17M | 29.50M | 28.99M | 32.39M |
| Income Before Tax Ratio | 9.57% | 15.37% | 10.83% | 8.48% | 10.96% | 14.52% | 18.43% | 19.19% | 23.88% | 21.64% | 22.97% | 16.69% | 14.84% | 15.80% | 19.89% | 4.65% | 14.24% | 13.68% | 10.97% | 11.78% | 13.92% |
| Income Tax Expense | 102.14M | 151.22M | 77.89M | 67.52M | 122.13M | 104.11M | 123.00M | 151.22M | 154.87M | 121.20M | 118.56M | 87.26M | 87.94M | 81.96M | 72.97M | 54.18M | 13.42M | 10.98M | 6.38M | 7.40M | 1.08M |
| Net Income | 217.75M | 503.86M | 292.09M | 198.11M | 308.42M | 375.38M | 440.48M | 387.68M | 500.79M | 386.92M | 367.05M | 208.45M | 135.37M | 204.50M | 258.47M | 15.02M | 36.09M | 30.18M | 22.99M | 21.59M | 31.30M |
| Net Income Ratio | 4.30% | 9.68% | 6.97% | 5.40% | 7.85% | 9.54% | 11.75% | 11.13% | 15.23% | 13.35% | 13.78% | 9.25% | 6.94% | 11.28% | 15.51% | 1.01% | 10.38% | 10.03% | 8.55% | 8.77% | 13.45% |
| EPS | 0.05 | 0.13 | 0.07 | 0.05 | 0.08 | 0.09 | 0.11 | 0.10 | 0.12 | 0.10 | 0.09 | 0.05 | 0.03 | 0.03 | 0.06 | 0.00 | 0.05 | 0.03 | 0.02 | 0.02 | 0.03 |
| EPS Diluted | 0.05 | 0.13 | 0.07 | 0.05 | 0.08 | 0.09 | 0.11 | 0.10 | 0.12 | 0.10 | 0.09 | 0.05 | 0.03 | 0.03 | 0.06 | 0.00 | 0.05 | 0.03 | 0.02 | 0.02 | 0.03 |
| Weighted Avg Shares Out | 4.05B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 2.22B | 1.20B | 1.20B | 1.20B | 1.20B |
| Weighted Avg Shares Out (Dil) | 4.05B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 4.02B | 2.22B | 1.20B | 1.20B | 1.20B | 1.20B |
Source: https://incomestatements.info
Category: Stock Reports